Alliancebernstein L.P. Sells 952,024 Shares of Maximus, Inc. (NYSE:MMS)

Alliancebernstein L.P. lessened its position in Maximus, Inc. (NYSE:MMS - Free Report) by 88.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,208 shares of the health services provider's stock after selling 952,024 shares during the period. Alliancebernstein L.P. owned about 0.22% of Maximus worth $9,421,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. UMB Bank n.a. increased its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after buying an additional 158 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after acquiring an additional 180 shares during the period. Hillsdale Investment Management Inc. increased its holdings in shares of Maximus by 0.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after acquiring an additional 230 shares during the last quarter. Bridge City Capital LLC raised its stake in Maximus by 0.9% in the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock valued at $2,128,000 after acquiring an additional 254 shares during the period. Finally, Inspire Advisors LLC lifted its holdings in Maximus by 3.1% during the 4th quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after purchasing an additional 258 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Maximus Price Performance

Maximus stock traded down $0.85 during mid-day trading on Tuesday, reaching $67.89. 114,217 shares of the company were exchanged, compared to its average volume of 547,222. The firm has a market cap of $3.84 billion, a PE ratio of 14.60 and a beta of 0.68. The company has a fifty day simple moving average of $67.75 and a 200-day simple moving average of $75.87. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is 25.81%.

Wall Street Analyst Weigh In

MMS has been the topic of several research analyst reports. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.